It was another busy week for Australia's top brokers. This led to the release of a large number of broker notes.
Three ASX broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Pilbara Minerals Ltd (ASX: PLS)
According to a note out of Morgans, its analysts have retained their add rating on this lithium miner's shares with a reduced price target of $4.60. Its analysts believe that weakness in the lithium industry could be coming to an end. As a result, it feels that Pilbara Minerals represents an attractive value opportunity. Particularly given how it believes the company's world class Pilgangoora leaves it well-placed to weather the lithium price storm. The Pilbara Minerals share price ended the week at $3.55.
ResMed Inc (ASX: RMD)
A note out of Goldman Sachs reveals that its analysts have reiterated their buy rating on this sleep treatment company's shares with an improved price target of $33.50. Goldman was impressed with ResMed's quarterly result and remains as positive as ever on its outlook. The broker also highlights that it continues to see asymmetric upside risk at current valuations. The ResMed share price was fetching $29.43 on Friday.
Woolworths Group Ltd (ASX: WOW)
Another note out of Goldman Sachs reveals that its analysts have retained their conviction buy rating on this supermarket giant's shares with a trimmed price target of $42.30. Although Goldman was disappointed with the performance of the company's New Zealand business, it was pleased with a stronger than expected half from the key Australian Food business. And with its shares trading on below their five-year average earnings multiples, Goldman sees it as the time to buy. The Woolworths share price ended the week at $36.44.
